Related Experiment Video
Updated: Jul 4, 2026
06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
[Leuconostoc sp in cancer patients: a descriptive study]
Sonia I Cuervo M1, Jorge Cortés L, Elizabeth Rodríguez R
1Departamento de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia. sicuervom@unal.edu.co
Summary
Leuconostoc species are rare opportunistic pathogens often found in critically ill patients, particularly those with cancer. This study reviews their infections in cancer patients, highlighting clinical conditions and treatment approaches.
Area of Science:
- Microbiology
- Infectious Diseases
- Oncology
Context:
- Leuconostoc species are increasingly recognized as opportunistic pathogens.
- These bacteria are frequently isolated in nosocomial infections, especially in critically ill patients and immunocompromised hosts.
- Commonly associated with bacteremia linked to intravascular devices and total parenteral nutrition.
Purpose:
- To describe the clinical characteristics and conditions of cancer patients experiencing Leuconostoc infections.
- To conduct a comprehensive literature review on Leuconostoc sp. infections in oncology patients.
- To enhance understanding of the spectrum of Leuconostoc infections in this vulnerable population.
Summary:
- The study details a series of cancer patients diagnosed with Leuconostoc infections.
- It outlines the associated clinical conditions and patient outcomes.
- A review of existing literature on Leuconostoc infections in cancer patients is presented.
Impact:
- Provides valuable insights into the clinical presentation and management of Leuconostoc infections in cancer patients.
- Highlights the importance of considering Leuconostoc as a potential pathogen in oncology settings.
- Contributes to the body of knowledge regarding rare opportunistic infections in immunocompromised individuals.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...